{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:44:21Z","timestamp":1764402261506},"reference-count":18,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2002,4,24]],"date-time":"2002-04-24T00:00:00Z","timestamp":1019606400000},"content-version":"vor","delay-in-days":631,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2000,8]]},"abstract":"<jats:p><jats:bold>BACKGROUND:<\/jats:bold> Occult viremia occurring before the appearance of HBsAg or after the disappearance of HBsAg is detectable by gene amplification technologies whose efficiency depends on nucleic acid preparation.<\/jats:p><jats:p><jats:bold>STUDY DESIGN AND METHODS:<\/jats:bold> To isolate HBV DNA from viremic plasma, immunoaffinity capture (IAC) of intact HBV with biotinylated pre\u2010S1 antibodies coupled to streptavidin\u2010coated magnetic beads was evaluated. IAC was compared with a silica\u2010gel method (Qiagen [QSG]) and its two modifications wherein the samples were heated with lysis buffer at 60<jats:sup>o<\/jats:sup>C for 10 minutes (QSG\u201060) or at 58\u00b0C for 60 minutes with proteinase\u2010K (QSG\u2010PK). Each HBV DNA sample was tested by heminested PCR amplification of the HBV gene sequences. A total of 36 coded serum samples were tested, including three HBsAg\u2010positive controls and 33 former chronic HBV carriers who had seroconverted (developed antibody to HBsAg [anti\u2010HBs]). Commercially available seroconversion panels (PHM 907, 911, and 922) were similarly tested for window\u2010period viremia.<\/jats:p><jats:p><jats:bold>RESULTS:<\/jats:bold> In the 33 former chronic HBV carriers who had seroconverted, IAC revealed HBV DNA in 17 samples, whereas it was revealed in only 11 samples by QSG\u2010PK (p = 0.031), 10 by QSG\u201060 (p = 0.016), and 9 by QSG (p = 0.0078). However, HBV DNA was not amplified from the 17 samples at 1\u2010in\u201010 dilutions; thus, they were considered to have low\u2010level viremia. IAC revealed HBV DNA as early as or earlier than the other methods in PHM 907, 911, and 922 panels.<\/jats:p><jats:p><jats:bold>CONCLUSION:<\/jats:bold> IAC is apparently an optimal method of sample preparation for amplification of HBV DNA in patients in the pre\u2010HBsAg window period, and for detecting low\u2010level viremia persistent in several individuals who were former chronic HBV carriers who had seroconverted (developed anti\u2010HBs).<\/jats:p>","DOI":"10.1046\/j.1537-2995.2000.40080910.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T22:43:38Z","timestamp":1047509018000},"page":"910-916","source":"Crossref","is-referenced-by-count":17,"title":["Hepatitis B virions isolated with antibodies to the pre\u2010S1 domain reveal occult viremia by PCR in Alaska Native HBV carriers who have seroconverted"],"prefix":"10.1111","volume":"40","author":[{"given":"M.J.","family":"Gandhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.G.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.J.","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.N.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199606273342601"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1995.35295125745.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3148.1998.00148.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0887-7963(94)70117-6"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(90)90971-3"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0166-0934(88)90126-7"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/160.1.37"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0042-6822(90)90031-L"},{"key":"e_1_2_6_10_2","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood.V81.4.1083.1083","article-title":"Detection of hepatitis B virus in plasma using flow cytometric analyses of polymerase chain reaction\u2010amplified DNA incorporating digoxigenin\u201011\u2010dUTP.","volume":"81","author":"Yang G","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_11_2","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archinte.1990.00390170087019","article-title":"Hepatitis B related sequelae. Prospective study in 1400 hepatitis B surface antigen\u2010positive Alaska native carriers.","volume":"150","author":"McMahon BJ","year":"1990","journal-title":"Arch Intern Med"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1101\/gr.2.3.241"},{"key":"e_1_2_6_13_2","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1128\/cdli.1.1.26-31.1994","article-title":"Flow cytometric immunodetection of human immunodeficiency virus type 1 proviral DNA by heminested PCR and digoxigenin\u2010 labeled probes.","volume":"1","author":"Yang G","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/147.3.531"},{"key":"e_1_2_6_15_2","article-title":"Quantitation of hepatitis B virus DNA from serum samples using a PCR capture hybridization assay.","author":"Lucia IG","year":"2023","journal-title":"Presented at the 9th General Meeting of the American Society for Microbiology"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2999980"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.239.4839.487"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1996.0019"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1128\/jcm.29.9.1804-1811.1991","article-title":"Rapid purification of hepatitis B virus DNA from serum.","volume":"29","author":"Boom R","year":"1991","journal-title":"J Clin Microbiol"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1537-2995.2000.40080910.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1537-2995.2000.40080910.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T18:42:57Z","timestamp":1698604977000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1537-2995.2000.40080910.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["10.1046\/j.1537-2995.2000.40080910.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1537-2995.2000.40080910.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}